Clywedog Therapeutics, Inc. (CLYD)

0.00

0.00 (0.00%)

No quote available

Clywedog Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Selling, General & Admin	1.64
Research & Development	13.19
Operating Expenses	14.83
Operating Income	-14.83
Interest Expense	-0.13
Other Non Operating Income (Expenses)	-3.41
EBT Excluding Unusual Items	-18.37
Other Unusual Items	1.37
Pretax Income	-17.01
Net Income	-17.01
Net Income to Common	-17.01
Net Income Growth	-
Shares Outstanding (Basic)	2
Shares Outstanding (Diluted)	2
Shares Change	-
EPS (Basic)	-11.25
EPS (Diluted)	-11.25
EPS Growth	-

Additional Metrics

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
EBIT	-14.83